Cost measurement Flashcards

1
Q

is the estimation of the cost of health interventions or services in a specific context

A

costing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

expenses incurred because of the illness

A

direct costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cost of all (medical) goods and services used for the provision of healthcare which are provided by the healthcare system, and further subdivided as fixed (covering capital, labor for installation and overhead costs), semi-fixed and variable costs (labor for use or operation of device).

A

Healthcare costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cost of all goods and services used for the provision of healthcare which are not directly provided by the healthcare system.

A

Non-Healthcare costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

covering capital, labor for installation and overhead costs

A

fixed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

labor for use or operation of device

A

variable costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the value of lost production because of reduced working time.

A

Indirect cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

the cost of pain and suffering associated with the treatment.

A

Intangible cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sometimes known as “productivity losses.”

A

indirect costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

These include the costs of lost work due to absenteeism or early retirement, impaired productivity at work (sometimes known as “presenteeism”), and lost or impaired leisure activity. Indirect costs also include the costs of premature mortality.

A

Indirect costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____ of pain, suffering, and grief are real, yet very difficult to measure and are often omitted from cost analyses

A

Intangible costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

should make clear whether average costs or marginal costs are being used in the analysis.

A

Assessments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

considers the total (or absolute) costs and outcomes of an intervention

A

average cost analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

considers how outcomes change with changes in costs (e.g., relative
to the standard of care or another comparator), which may provide more information about how to use resources efficiently.

A

marginal cost analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

This perspective is similar to the healthcare payer perspective but accounts for all monetary costs of healthcare, regardless of who bears the cost.

A

Healthcare sector

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

This perspective includes only those monetary costs (e.g., treatment costs and other health service resource use associated with disease management) incurred by a (typically third party) healthcare payer (e.g., Medicare/Medicaid, British national health service, a health maintenance organization, etc.).

A

Healthcare payer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A key distinction between the healthcare sector and healthcare payer perspectives is that the healthcare sector perspective includes _______

A

patients’ out-of-pocket costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

This perspective accounts for cost components beyond those captured by the healthcare sector perspective, including patient time, patient transportation, unpaid caregiver time, and productivity loss.

A

Limited societal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

t or f

Limited societal includes spillover impacts affecting sectors other than healthcare, such as education.

A

F

EXCLUDES

20
Q

broader than the limited societal perspective

A

societal perspective

21
Q

It represents the overall public interest by including all resources that could be used for other purposes.

A

societal perspective

22
Q

The analysis accounts for cost impacts affecting at least one of these other sectors, such as the environment, education, or the justice system.

A

societal perspective

23
Q

This designation indicates that the authors did not provide sufficient information for us to determine the type of costs or benefits included in the analysis

A

Not stated/could not be determined

24
Q

reflects the time preference for benefits earlier rather than later; it also reflects the opportunity costs of capital, i.e., whatever returns on investment that could have been gained if resources had been invested elsewhere.

A

Discounting

25
Q

allows comparisons involving costs and benefits that flow differently over time.

A

Discounting

26
Q

should also correct for the effects of inflation (which is different from the time preference accounted for by discounting), such as when cost or cost-effectiveness for one year is compared to another year.

A

Cost analyses

27
Q

Any estimate of costs, outcomes, and other variables used in a cost analysis is subject to some uncertainty.

A

Sensitivity analysis

28
Q

should be performed to determine if plausible variations in the estimates of certain variables thought to be subject to significant uncertainty affect the results of the cost analysis.

A

Sensitivity analysis

29
Q

core aspect of HTA which involves comparing the costs of its implementation with the health
benefits it generates, allowing for a comprehensive evaluation of resource
utilization.

A

assess the cost-effectiveness

30
Q

Data collection methods

A

clinical data analysis, cost-utility analysis, patient surveys, and healthcare
provider interviews

31
Q

HTA considers different categories of costs:

A

direct medical costs, direct non-medical costs, and indirect
costs

32
Q

e.g., drugs, procedures, hospital stays

A

direct medical costs

33
Q

e.g., patient travel, lost productivity

A

direct non-medical costs

34
Q

e.g., societal impact on caregivers

A

indirect
costs

35
Q

Evaluating the cost-effectiveness of a new drug compared to existing
treatments by considering factors like drug price, potential reduction in
hospital admissions, and improved quality of life.

A

Comparing new drug treatments

36
Q

Analyzing the resource implications of a novel medical device, such as its
impact on operating room time, length of hospital stays, and associated
costs.

A

Assessing new medical devices

37
Q

Examining the potential cost savings of preventive measures like screening
programs by considering reduced future healthcare needs.Examining the potential cost savings of preventive measures like screening
programs by considering reduced future healthcare needs.Examining the potential cost savings of preventive measures like screening
programs by considering reduced future healthcare needs.

A

Evaluating preventative healthcare interventions

38
Q

costing process

A
  1. cost identification
  2. cost measurement
  3. valuation
39
Q

deciding which resources will appear in the numerator

A

cost identification

40
Q

measuring the physical quantities of these resources

A

cost measurement

41
Q

process of expressing resources in monetary values

42
Q

is a resource that is known to be imported, or could have been imported
(so called potentially traded goods’ ) such as medical equipment, supplies and
pharmaceuticals.

A

traded good

43
Q

Using pre-established costs per unit of
service (e.g., cost per hospital bed day).

A

Standard unit costs

44
Q

Detailed calculation of individual cost components
for a specific intervention.

A

Micro-costing

45
Q

Assigning a cost to intangible benefits or societal
values that may not have a readily available market price.

A

Shadow pricing